These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 919566)

  • 1. [Induced abortion with prostaglandin F2alpha and a new prostaglandin E2 derivative].
    Lichtenegger W
    Wien Med Wochenschr; 1977 Sep; 127(17):536-8. PubMed ID: 919566
    [No Abstract]   [Full Text] [Related]  

  • 2. [First results with a new prostaglandin E2-derivate (author's transl)].
    Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Schüssler B; Koch R; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Dec; 37(12):1030-8. PubMed ID: 604150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of differentiated PGE2, PGF2alpha and prostaglandin-derivative administration for avoidance of complications in abortion induction].
    Cornely M
    Arch Gynecol; 1979 Jul; 228(1-4):413-4. PubMed ID: 485400
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction of second trimester abortions with 15-(S)-methyl prostaglandin F2alpha by intra-uterine and intramuscular routes.
    Hingorani V; Agarwal N; Bhadury R; Singh CM; Baliga N; Tekumalla L
    J Indian Med Assoc; 1976 Jun; 66(11):279-83. PubMed ID: 977973
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraamniotic prostaglandin F2alpha for midtrimester abortion.
    Ballard CA; Quilligan EJ
    Adv Biosci; 1973; 9():551-4. PubMed ID: 4805867
    [No Abstract]   [Full Text] [Related]  

  • 6. Termination of mid-term spontaneous and missed abortions by extra-amniotic injection of a single prostaglandin F2alpha dose.
    Kerekes L; Domokos N
    Ther Hung; 1977; 25(3):102-4. PubMed ID: 929474
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience using intraamniotic prostaglandin F2alpha for midtrimester abortion in 600 patients.
    Anderson GG; Steege JF
    Obstet Gynecol; 1975 Nov; 46(5):591-5. PubMed ID: 1196565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1st clinical experiences with prostaglandin E derivative sulprostone in extraamnial abortion induction].
    Briel RC; Lippert T; Kidess E; Roemer VM
    Arch Gynecol; 1979 Jul; 228(1-4):425. PubMed ID: 485413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Theraupeutic intra-amniotic, transabdominal induction of abortion in the 2nd trimenon using prostaglandin F 2alpha].
    Sacha E; Gigon U; Dreher E; Jann FX
    Gynakol Rundsch; 1976; 16(4):261-3. PubMed ID: 1035876
    [No Abstract]   [Full Text] [Related]  

  • 10. Concurrent use of prostaglandin F2alpha and laminaria tents for induction of midtrimester abortion.
    Duenhoelter JH; Gant NF; Jimenez JM
    Obstet Gynecol; 1976 Apr; 47(4):469-72. PubMed ID: 1256730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of therapeutic abortion by intra-amniotic and intravenous administration of prostaglandin F2-alpha in the second trimester of pregnancy].
    Otoka A; Otoka K
    Wiad Lek; 1982 Sep; 35(15-16):969-72. PubMed ID: 6959421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulprostone, a new prostaglandin E2 derivative (author's transl)].
    Schüssler B; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1697-701. PubMed ID: 520164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins: overview in obstetrics and gynecology.
    Singh EJ; Zuspan FP
    J Reprod Med; 1974 May; 12(5):211-4. PubMed ID: 4599109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [15-Methyl-PGF2alpha (i.m.) treatment in the 2d pregnancy trimester compared to intravenous administration of prostaglandin F2alpha and prostaglandin E2].
    Mickan H; Landherr F; Zander J
    Arch Gynecol; 1979 Jul; 228(1-4):411-2. PubMed ID: 485398
    [No Abstract]   [Full Text] [Related]  

  • 16. 15 (S)-15-methyl-prostaglandin F2alpha: myometrial response and abortifacient efficacy.
    Wiqvist N; Béguin F; Bygdeman M; Toppozada M
    Adv Biosci; 1973; 9():831-42. PubMed ID: 4805896
    [No Abstract]   [Full Text] [Related]  

  • 17. [Induction of second trimester abortion with intra-amniotic prostaglandin F2 alpha].
    Lange AP; Gammelgaard J
    Ugeskr Laeger; 1982 Mar; 144(13):946-9. PubMed ID: 7101534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulprostone, an uterospecific prostaglandin E2 derivative. Significance for abortion with special reference to various administration forms].
    Schmidt-Gollwitzer M; Schüssler B; Schmidt-Gollwitzer K
    Arch Gynecol; 1979 Jul; 228(1-4):403. PubMed ID: 485390
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic abortion by intraamniotic administration of prostaglandin F2alpha.
    Nyberg R
    Adv Biosci; 1973; 9():533-7. PubMed ID: 4805864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intramural-intrauterine administration of prostaglandin E2 derivative for abortion induction in semi-hospitalized care in the operating room].
    Wiechell H
    Arch Gynecol; 1979 Jul; 228(1-4):409-10. PubMed ID: 485396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.